CSIMarket
 

Innovation1 Biotech Inc   (MYYZ)
Other Ticker:  
 

Innovation1 Biotech Inc 's Working Capital Per Sales

MYYZ's Working Capital and Revenue growth



MYYZ Working Capital Per Revenue (Aug 31 2023)
IV. Quarter
(May 31 2023)
III. Quarter
(Feb 28 2023)
II. Quarter
(Nov 30 2022)
I. Quarter
(Aug 31 2022)
IV. Quarter
Y / Y Working Capital Change - - - - -
Y / Y Revenue Change - - - - -
Working Capital Per Revenue - - - - -
Total Ranking # # # # #
Seq. Working Capital Change - - - - -
Seq. Revenue Change - - - - -





Comment on MYYZ's Working Capital Per Revenue in the fourth quarter 2023


Within Healthcare sector Innovation1 Biotech Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q4 2023 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Innovation1 Biotech Inc 's Working Capital $ -3 Millions Visit MYYZ's Balance sheet
Innovation1 Biotech Inc 's Revenues $ 0 Millions Visit MYYZ's Income Statement
Where are MYYZ's Sales coming from? Visit MYYZ's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Aug 31 2023, within Healthcare Sector Working Capital Per Revenue
Date modified: 2024-01-18T14:59:05+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com